Page last updated: 2024-09-05

erlotinib hydrochloride and Eosinophilia, Tropical

erlotinib hydrochloride has been researched along with Eosinophilia, Tropical in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Lee, JY; Lin, CF; Liu, SY; Lo, TK; Su, PL	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Eosinophilia, Tropical

Article	Year
Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report. Thoracic cancer, 2022, Volume: 13, Issue:3 Topics: Afatinib; Carcinoma, Non-Small-Cell Lung; Eosinophilia; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Quinazolines	2022

Article

Year

Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report.

Thoracic cancer, 2022, Volume: 13, Issue:3

Topics: Afatinib; Carcinoma, Non-Small-Cell Lung; Eosinophilia; ErbB Receptors; Erlotinib Hydrochloride; Exanthema; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Quinazolines

2022